United States Cardiac Imaging Software Market Size, Share & Trends Analysis Report By Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound Imaging, X-ray Imaging, Others), By Application (Diagnostic Imaging, Image Guided Treatment), By End User (Hospitals, Diagnostics Centers, Others) and Forecasts, 2026-2034

Last Updated: September 01, 2026 | Author: Debashree Bora | Format:

United States Cardiac Imaging Software Market Size

The United States cardiac imaging software market size was valued at USD 1.48 billion in 2025 and is projected to grow from USD 1.62 billion in 2026 to reach USD 3.25 billion by 2034, growing at a CAGR of 9.15% during the forecast period 2026–2034.

The market is driven by advancements in technologies, increasing prevalence of cardiovascular diseases (CVDs), and significant investments in healthcare infrastructure. In addition, modalities such as MRI and diagnostic applications play a pivotal role in shaping the market’s growth trajectory, supported by expanding adoption across hospitals and specialty clinics.

Download a Free Sample To learn more about this report.

Modality Insights

Magnetic resonance imaging dominates the modality segment and is expected to grow at a CAGR of 8.5% over the forecast period, driven by its superior diagnostic capabilities for complex cardiac conditions. Ongoing advancements in resolution and AI-assisted software enhancements fuel its adoption. Additionally, CT imaging offers rapid and accurate cardiac assessments, particularly for detecting coronary artery disease. Innovations in low-dose imaging and high-speed scanners support growth in this segment.

United States Cardiac Imaging Software Market Size By Segments

Request Customizationto receive a tailored report.

Application Insights

Diagnostic imaging leads the application segment and is expected to grow at a CAGR of 7.2% during the forecast period, supported by the increasing prevalence of chronic cardiovascular conditions. Similarly, pre-operative imaging software facilitates precise surgical interventions, particularly for complex valve replacements and bypass surgeries.

End User Insights

Hospitals dominate the end-user segment and are expected to grow at a CAGR of 8.1% over the forecast period, attributed to high patient footfall and the availability of advanced diagnostic facilities. Specialty clinics are emerging as significant contributors to market growth, leveraging software solutions for focused cardiovascular care.

United States Cardiac Imaging Software Market Share By Segments

Speak to an Analystto discuss market opportunities.

United States Cardiac Imaging Software Market Regional Insights

The market is characterized by regional disparities in healthcare infrastructure, technological adoption, and investment in cardiac imaging solutions. Leading cities drive innovation and accessibility.

New York boasts extensive advanced cardiac imaging software adoption as a medical research and healthcare innovation hub. Institutions like Mount Sinai Heart integrate AI-based tools to enhance diagnostic accuracy and patient outcomes.

Los Angeles’s high prevalence of cardiovascular diseases drives significant investment in diagnostic technologies. Cedars-Sinai Medical Center’s adoption of 3D imaging software exemplifies the integration of cutting-edge solutions.

Houston is known for its world-class healthcare facilities, including the Texas Medical Center, which emphasizes precision medicine and advanced imaging. Collaborative projects with tech companies bolster innovation in cardiac care.

Chicago’s robust healthcare network and focus on medical education support the adoption of advanced diagnostic tools. Northwestern Medicine’s initiatives in tele-imaging and cloud-based platforms illustrate regional growth.

Boston leverages academic partnerships to develop next-generation software, a leading city in healthcare R&D. Institutions like Massachusetts General Hospital pioneer advancements in AI-driven cardiac diagnostics.

List of Key and Emerging Players in United States Cardiac Imaging Software Market

FUJIFILM Holdings Corporation

Koninklijke Philips N.V

Siemens Healthineers AG

GE HealthCare

CANON MEDICAL SYSTEMS CORPORATION

NeoSoft LLC

Tempus AI Inc. (Arteys)

Pie Medical Imaging B.V. (Esaote group)

Medis Medical Imaging Systems B.V.

Circle Cardiovascular Imaging Inc.

SymphonyAI

Key Industry Developments

June 2026

GE HealthCare launched an AI-powered cardiac imaging software platform featuring advanced automation for echocardiography, CT, and MRI analysis, improving clinical workflow and diagnostic accuracy.

May 2026

Philips expanded its cardiovascular imaging portfolio by introducing enhanced AI-enabled cardiac ultrasound and image analysis software for hospitals and cardiac care centers across the United States.

March 2026

Siemens Healthineers introduced next-generation cardiac imaging software with advanced 3D visualization, automated measurements, and cloud-enabled workflow integration for cardiovascular diagnostics.

November 2025

Circle Cardiovascular Imaging launched an upgraded version of its cvi42 cardiovascular imaging platform with new AI-assisted analysis tools for cardiac MRI and CT imaging.

Report Scope

Segmentation

By Modality 5

Computed Tomography
Magnetic Resonance Imaging
Ultrasound Imaging
X-ray Imaging
Others

By Application 2

Diagnostic Imaging
Image Guided Treatment

By End User 3

Hospitals
Diagnostics Centers
Others

Competitive Coverage FUJIFILM Holdings Corporation · Koninklijke Philips N.V · Siemens Healthineers AG · GE HealthCare · CANON MEDICAL SYSTEMS CORPORATION

Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The United States cardiac imaging software market size was valued at USD 1.48 billion in 2025 and is projected to grow from USD 1.62 billion in 2026 to reach USD 3.25 billion by 2034.

The US market growth rate growing at a 9.15% from 2026 to 2034.

Advancements in Cardiac Imaging Technologies and Rising CVD Prevalence, are the key growth factor driving the market

Currently, Magnetic resonance imaging dominates the modality segment

About the Author

Debashree Bora

Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.